Literature DB >> 9397937

Role of specific isoforms of protein kinase C in angiotensin II and lipoxygenase action in rat adrenal glomerulosa cells.

R Natarajan1, L Lanting, L Xu, J Nadler.   

Abstract

Evidence indicates that the lipoxygenase (LO) pathway of arachidonic acid is a key mediator of angiotensin II (AII)-induced aldosterone synthesis in adrenal glomerulosa cells. Although protein kinase C (PKC) may play a role in AII action, the precise PKC isoforms involved and whether LO products can activate PKC is not clear. We therefore evaluated the effect of AII and LO products such as 12- and 15-hydroxyeicosatetraenoic acids (HETEs) on PKC activation in isolated rat adrenal glomerulosa cells. PKC activity was measured by the phosphorylation of a PKC specific peptide while the PKC isoforms were identified by Western immunoblotting using antibodies that recognize the alpha, beta, gamma or epsilon isoforms of PKC. Treatment of the cells for 15 min with AII (10[-8]M) or the LO products 12- or 15-HETE caused a marked increase in PKC activity in membrane fractions with reciprocal decreases in the cytosolic PKC activity. Rat glomerulosa cells expressed only the alpha, and epsilon isoforms of PKC. AII increased membrane bound levels of both PKC-alpha and -epsilon (1.9- and 1.5-fold, respectively), whereas the LO products predominantly activated PKC-epsilon. Reciprocal decreases in immunoreactive cytosolic PKC levels were seen. AII-induced aldosterone synthesis was blocked by H-7 and retinal as well as by a PKC-specific pseudosubstrate inhibitor, PKC(19-36). These results suggest that AII and LO pathway-induced actions in the adrenal glomerulosa may be mediated by specific PKC isoforms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9397937     DOI: 10.1016/0303-7207(94)90219-4

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  8 in total

Review 1.  Acute and chronic regulation of aldosterone production.

Authors:  Namita G Hattangady; Lawrence O Olala; Wendy B Bollag; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-08-04       Impact factor: 4.102

2.  Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradation.

Authors:  Shigeru Shibata; Juan Pablo Arroyo; María Castañeda-Bueno; Jeremy Puthumana; Junhui Zhang; Shunya Uchida; Kathryn L Stone; TuKiet T Lam; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

3.  Inhibition of endothelin- and phorbol ester-stimulated tyrosine kinase activity by corticotrophin in the rat adrenal zona glomerulosa.

Authors:  S Kapas; J P Hinson
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

4.  Murine 12/15-lipoxygenase regulates ATP-binding cassette transporter G1 protein degradation through p38- and JNK2-dependent pathways.

Authors:  Melissa H Nagelin; Suseela Srinivasan; Jerry L Nadler; Catherine C Hedrick
Journal:  J Biol Chem       Date:  2009-08-27       Impact factor: 5.157

Review 5.  12-lipoxygenases and 12(S)-HETE: role in cancer metastasis.

Authors:  K V Honn; D G Tang; X Gao; I A Butovich; B Liu; J Timar; W Hagmann
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

6.  Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells.

Authors:  Marpadga A Reddy; Saurabh Sahar; Louisa M Villeneuve; Linda Lanting; Rama Natarajan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-12-18       Impact factor: 8.311

Review 7.  12/15-lipoxygenase during the regulation of inflammation, immunity, and self-tolerance.

Authors:  Stefan Uderhardt; Gerhard Krönke
Journal:  J Mol Med (Berl)       Date:  2012-09-15       Impact factor: 4.599

Review 8.  12- and 15-lipoxygenases in adipose tissue inflammation.

Authors:  Banumathi K Cole; David C Lieb; Anca D Dobrian; Jerry L Nadler
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-08-20       Impact factor: 3.072

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.